EFFECTS OF OMEGA-3 AND PROTEIN SUPPLEMENTATION ON NUTRITIONAL AND INFLAMMATORY INDICES IN HEMODIALYSIS PATIENTS – A PILOT STUDY.  by Zulfitri, Azuan Mat Daud et al.
prohypertensive role via vasoconstriction in CYP4F2 TG mice. To investigate
antihypertensive action of 20-HETE via natriuresis in CYP4F2 TG mice , we fed
TG mice a high salt (4% NaCl) diet for 2 weeks, and measured their systolic
blood pressure (SBP), urine sodium concentration, urine volume, and urinary
20-HETE excretion. The expression of renal Naþ-Kþ-2Cl- cotransporter, isoform
2 (NKCC2) was detected by Real-time PCR and Western blot. The results
showed that SBP was not changed, but the urinary sodium excretion and
urinary 20-HETE excretion were promoted by high salt intake in TG mice.
NKCC2 protein was reduced by high salt intake, but its mRNA was not. These
data suggest that 20-HETE of CYP4F2 TG mice exert natriuresis in renal
adaptation to elevated Naþ intake, in which reduction of renal NKCC2 protein
was involved through high salt-induced posttranscriptional regulation.
http://dx.doi.org/10.1016/j.krcp.2012.04.607
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Background: Alterations in innate immunity play a role in renal damage in
experimental models but the role of these alterations in the progression of CKD
in humans is still poorly deﬁned. Procalcitonin (PCT), is a biomarker of innate
immunity produced by C-cells of the thyroid and by the adipose tissue.
Objectives: We measured serum plasma PCT levels in a cohort of 670
patients with stage 3–5 CKD and tested the relationship between this
biomarker metrics of adiposity, proteinuria, GFR and progression to kidney
failure over a 3 year follow-up. None of the patients had intercurrent
infectious or acute inﬂammatory processes.
Methods: PCT was measured by an ultrasensitive immunoluminometric
assay. The GFR was estimated by a Cystatin-C based equation. The
relationship between PCT and renal events was tested by multivariate
Cox’s regression and interaction analysis.
Results: Procalcitonin exceeded the upper limit of the normal range
(40.064 ng/mL) in 492 patients (67 %) while the corresponding ﬁgure
for high sensitivity CRP (41 mg/L) was 170 (%). PCT was higher (Po0.001)
in males and strongly associated with the GFR (r¼) as well as diabetes
(P¼0.004) and a history of cardiovascular (CV) events (P¼0.007).
Furthermore PCT was inversely related with Hb (r¼0.16, Po0.001) and
with serum albumin (r¼0.10, P¼0.009) and directly associated with CRP
(r¼0.23, Po0.001) and with white blood cells count (r¼0.12, P¼0.002). Of
note, PCT was higher (Po0.001) in patients with large waist hip ratio (IVth
quartile) than in those normal or high normal WHR (1st to 3rd quartiles).
During the follow up, PCT predicted the combined renal end-point (30%
GFR loss, dialysis or transplantation) (HR for 1 ng/ml increase: 2.37,
95%CI:1.25–4.48, P¼0.009) in a model adjusting for age, sex, diabetes, BP,
smoking, cholesterol, background cardiovascular events and PCT interacted
with baseline GFR in predicting renal outcomes. Indeed the risk of for the
combined end-point was minimal in patients with low PCT and high GFR
and maximal in those with low GFR and high PCT.
Conclusions: Plasma procalcitonin is a more sensitive biomarker of innate
immunity than CRP in CKD patients and in part reﬂects excessive adiposity.
High PCT in CKD patients predicts progression toward kidney failure. These
results are compatible with the hypothesis that alterations in innate
immunity play a role in the progression of CKD in humans.
http://dx.doi.org/10.1016/j.krcp.2012.04.608
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Intervention to correct malnutrition and chronic inﬂammation in dialysis
patients is often impeded by poor compliance due to medical and
socioeconomic barriers. Therefore we performed a pilot study to
investigate the technical feasibility of ‘‘directly observed treatment’’ of
nutritional supplementation (protein and omega-3 fatty acids) and its
effects on nutritional and inﬂammatory markers in low socio-economic
status hemodialysis population. Sixty-three eligible patients agreed to
participate. Two intervention groups received 30 mL of a liquid protein
supplement plus either 2.4 gm omega-3 (1.8 gm eicosapentaenoic acid þ
0.6 gm docosahexaenoic acid) or a placebo, three times per week after their
routine dialysis session for 6 months. Serum albumin, plasma lipids, and
other indicators of nutritional and inﬂammatory status were measured.
Statistical differences after treatment and between groups were
determined using paired t-test and independent t-test, respectively.
Directly observed nutritional supplementation resulted in a signiﬁcant
improvement in the LDLC/HDLC ratio in the omega-3 group as compared to
the placebo group (P ¼ 0.043). For the omega-3 group, serum albumin was
also marginally higher after 6 months as compared to baseline (P ¼ 0.07).
Other nutritional and inﬂammatory markers were unaffected by
intervention. In conclusion, ‘‘Directly observed treatment’’ is technically
feasible with an omega-3 based supplement (as opposed to a pure protein
supplement) showed beneﬁcial effects on the lipid proﬁle.
http://dx.doi.org/10.1016/j.krcp.2012.04.609
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OF FLAXSEED AND OLIVE OILS ON CONSTIPATION OF HEMODIALYSIS
PATIENTS: PRELIMINARY RESULTS.
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Mineral oil has been used in the treatment of constipation in
hemodialysis patients. Edible oils could also be a good option for treating
this symptom. Therefore we aimed to investigate the effect of ﬂaxseed and
olive oils on constipation of hemodialysis patients. This trial was conducted
for 4 weeks. Constipation was diagnosed by Rome III criterion. Thirty six
constipated patients (18M, 51.0712.2 years) were randomized into
Mineral oil (MG; n¼11), Flaxseed oil (FG; n¼11) and Olive oil (OG; n¼14)
groups. The initial dose of each oil was 4 ml/d and was adjusted as needed.
There was no difference in total oil used among groups (150.7743.7 ml,
165.8753.3 ml, 144.4749.5 ml, respectively; p¼0.61). The prevalence of
each Roma III criterion item was similar among the groups.
MG (%) OG (%) FG (%)
0 wk4 0 wk4 0 wk4
Abdominal pain 54.5 27.3 36.4 9.1* 9.1 0
Straining on defecation 30.8 7.7 34.6 11.5* 34.6 15.4
Lumpy or hard stools 32.3 9.7 39.7 12.9 29.0 12.9
Incomplete evacuation 28.1 18.8 43.8 28.1 28.1 18.8
Anorectal obstruction 29.2 12.5 45.8 4.2* 25.0 12.5
Manual maneuvers 25.0 0 50.0 0* 25.0 0
o 3 evacuation/week 36.8 5.3* 31.6 10.5* 31.6 15.8
This preliminary result suggests that olive oil could be a healthy
alternative on treatment of constipation in hemodialysis patients.
n
po0.05; 0 vs wk4.
http://dx.doi.org/10.1016/j.krcp.2012.04.610
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In Hong Kong, more than 3,000 patients with end-stage renal failure
(ESRF) on CAPD in 20091. Protein-energy malnutrition and volume
overload are common problems in CAPD patients and associated with high
morbidity and mortality2-6. Hyperphosphatemia is also a frequent
complication in Chinese CAPD patients and is associated with development
of renal bone disease or osteodystrophy7. The Kidney Dialysis Outcomes
Quality Initiative (KDOQI) guidelines suggested a combination of valid,
complementary measures should be used to assess nutritional status in
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